Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 650x76px
Organisation › Details

Cancer Research Technology Ltd. (CRT)

Cancer Research Technology (CRT) is a specialist commercialisation and development company, which aims to develop new discoveries in cancer research for the benefit of cancer patients. CRT works closely with leading international cancer scientists and their institutes to protect intellectual property arising from their research and to establish links with commercial partners. CRT facilitates the discovery, development and marketing of new cancer therapeutics, vaccines, diagnostics and enabling technologies. CRT is a wholly owned subsidiary of Cancer Research UK, the world's leading cancer charity dedicated to saving lives through research. *


Period Start 2002-10-01 existent
  Group Cancer Research UK (CRUK) (Group)
Products Industry IP services
  Industry 2 drug discovery
Person Person Blundy, Keith (Storm Therapeutics 201702– CEO before 10y CEO of Cancer Research Technology)
Region Region London, Greater London
  Country United Kingdom (GB)
  Street Sardinia House, Sardinia Street
  City WC2A 3NL London
  Tel +44-20-7269-3640
    Address record changed: 2008-12-07
Basic data Employees n. a.
    * Document for �About Section�: Centre for Drug Research and Development, The (CDRD). (1/21/13). "Press Release: Alliance of Translational Research Centres Established to Accelerate Global Drug Development". London & Vancouver, BC.
Record changed: 2018-10-30


Picture [LSA] – The Business Web Portal 650x89px

More documents for Cancer Research UK (CRUK) (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 650x76px

» top